Search - tctmd.com

Displaying 61 - 80 of 113

Sort: Relevancy | Date

Presentation TCT 2013

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

Presenter: Michael Haude

October 29, 2013

Presentation TCT 2013

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Presenter: Peter Smits

October 29, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

Presenter: Piotr Buszman

October 28, 2013

Presentation TCT 2013

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Presenter: Michael Haude

October 27, 2013

Presentation

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

Presenter: F. Liistro

October 14, 2013

Presentation

A Randomized Comparison of Paclitaxel-coated Balloon Catheter With Conventional Balloon Angioplasty In Patients With BMS, DES Restenosis

Presenter: Seiji Habara

September 23, 2013

Presentation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Presenter: George D. Dangas

September 16, 2013

Presentation

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Presenter: Jochen W?hrle

July 09, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Presenter: Antonio Micari

April 03, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

Presentation

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

Presenter: Robert A. Byrne

February 07, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Krzysztof Milewski, Piotr Buszman, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp

January 31, 2013

Presentation TCT 2013

Biological Efficacy and Vessel Healing of Second Generation Paclitaxel Coated Balloons: A Comparative Study with the original PACCOCATH Technology in the Ilio-Femoral In-Stent...

Presenter: Piotr Buszman, Armando Tellez, Maxwell Afari, Jenn McGregor, Yanping Cheng, Gerard Conditt, Serge Rousselle, Greg Kaluza, Juan Granada

January 31, 2013

Advertisement

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

A Randomized Comparison of Paclitaxel-coated Balloon Catheter With Conventional Balloon Angioplasty In Patients With BMS, DES Restenosis

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Biological Efficacy and Vessel Healing of Second Generation Paclitaxel Coated Balloons: A Comparative Study with the original PACCOCATH Technology in the Ilio-Femoral In-Stent...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content